GenVec to receive $2.3M from NIAID for HIV vaccine candidate production

Published on September 26, 2009 at 12:59 AM · 1 Comment

GenVec, Inc. (Nasdaq: GNVC) announced today that the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), has executed its third option period (year four) under a previously announced, five-year contract with GenVec valued at up to $52 million for the production of HIV vaccines.

GenVec will receive up to $2.3 million for the fourth year, which will support the generation of HIV vaccine candidates with GenVec's alternate adenovirus serotype technology.

www.genvec.com

e57a23f9-1808-46df-8396-2d8eb30f4c75|0|.0

Posted in: Pharmaceutical News

Tags: Adenovirus, Allergy, Cancer, Esophageal Cancer, Head and Neck Cancer, Malaria, Pancreatic Cancer, Vaccine, Virus

Fully funding global health initiatives critical in AIDS fight"With donor support flagging around the world, U.S. leadership is crucial. Congress must fully fund ...
Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinenceThe U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incont...
Cervical cancer vaccine target falls short: ReportData from the Australian federal government shows that the target to immunize 80 per cent of 12-year...
Pulitzer Prize-winning photojournalist takes new challenge to combat cancerPulitzer Prize-winning photojournalist John Kaplan has taken on a new challenge: to give away 10,000...
MGH researchers discover massive overexpression of DNA sequences in cancer cellsMassachusetts General Hospital Cancer Center researchers have discovered a previously unknown featur...
Research article addresses the relationship between PEG and GERGastroesophageal reflux (GER) is a common problem in mechanically ventilated patients and contribute...
Considerable disparities in survival found among patients with head and neck cancerA new analysis finds considerable disparities in survival related to race and socio-economic status ...
Polio strikes IndonesiaOne decade after recording the last case of polio in Indonesia, a 20 month-old girl from Sukabumi di...
New treatment strategy for brain cancerVirginia Commonwealth University Massey Cancer Center researchers have found that combining ionizing...

Comments

HIV vaccine

Carl Horton says:

September 26, 2009 at 8:47 AM

I'm very glad to hear that HIV vaccine is on the way now maybe I can live normal life. Can I please be notified upon realease of vaccine?

Reply »

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.